<!DOCTYPE HTML>

<html>
	<head>
		<title>Pharmaceutical Industry in China</title>
		<meta charset="utf-8" />
		<meta name="viewport" content="width=device-width, initial-scale=1, user-scalable=no" />
		<link rel="stylesheet" href="assets/css/main.css" />
	</head>
	<body class="is-preload">

		<!-- Wrapper -->
			<div id="wrapper">

				<!-- Main -->
					<div id="main">
						<div class="inner">

							<!-- Header -->
					

							<!-- Content -->
								<section>
									<header class="main">
										<h1>Pharmaceutical Industry in China</h1>
									</header>

									<span class="image main"><img src="images/cover.png" alt="" /></span>

		
									
									<hr class="major" />

									<h2>Industry Value Chain</h2>
									<h3>The Life of a Drug</h3>
									<p style="text-align:justify">The major life stage of a drug includes Research and development, Raw materials manufacturing, and distribution, shown in the graph below. Along the value chain, the key players include pharmaceutical companies, manufacturers, wholesalers, hospitals, pharmacies, and ultimately delivered to end patients.</p>
									<span class="image fit"><img src="images/drug_life.png" alt="" /></span>
									<ol>
										<li ><b><u>Research and Development:</u></b> Initiated with Contract research organizations (CRO), main stages include initial development, preclinical research, and clinical trial</li>
										<li><b><u>Licensing:</u></b> Major steps prior to drug licensing include drug registration, quality control, and labeling.</li>
										<li><b><u>Raw Materials Manufacturing:</u></b> Drug manufacturing includes both imported and local drugs. For imported drugs, most are in finished dosage forms or bulk packets when shipped, while local manufacturers hired are mainly contract manufacturing organizations.</li>
										<li><b><u>Distribution:</u></b> Over the counter (OTC) drugs and prescription drugs are the 2 main categories.</li>
									</ol>
									<br/>
									<h3>Demystifying Drug R&D and registration</h3>
									<p style="text-align:justify">Developing a new prescription medicine that gains marketing approval is estimated to cost drug makers $2.6 billion on average. The overall chance that a drug entering clinical development will be approved for marketing is just under 12% in China. <br/>(Source: NMPA)</p>
									<span class="image fit"><img src="images/Demystifying.png" alt="" /></span>
									<br/>
									<h3>Supply Chain and Major Players (Competitive Landscape)</h3>
									<p style="text-align:justify">The value chain of China’s pharmaceutical industry includes R&D, Manufacturing, Middlemen distributors, and end distribution.</p>
									<ul>
																<li><b><u>Research and Development </u></b>is the upstream of the industry supply chain, including pharmaceutical company’s in house R&D team, Contract Research Companies (CRO), and research institutes and universities. </li>
																<li><b><u>Manufacturing </u></b>industry players include pharmaceutical companies themselves, Contract manufacturing organizations (CMO), and raw material suppliers.</li>
																<li><b><u>Middlemen distributers </u></b>include wholesalers and E-commerce players, and this part of the industry chain is largely disrupted due to online purchase trends with China’s rapid growth in e-commerce.</li>
																<li><b><u>End consumer distributors </u></b>include hospitals and pharmacies, providing prescription drugs and OTC drugs to consuemrs.</li>
															</ul>
									<h5 style="text-align: center">Major players in the industry</h5>
									<span class="image fit"><img src="images/cl.png" alt="" /></span>
									

									<hr class="major" />

									<h2>Lorem aliquam bibendum</h2>
									<p>Donec eget ex magna. Interdum et malesuada fames ac ante ipsum primis in faucibus. Pellentesque venenatis dolor imperdiet dolor mattis sagittis. Praesent rutrum sem diam, vitae egestas enim auctor sit amet. Pellentesque leo mauris, consectetur id ipsum sit amet, fergiat. Pellentesque in mi eu massa lacinia malesuada et a elit. Donec urna ex, lacinia in purus ac, pretium pulvinar mauris. Curabitur sapien risus, commodo eget turpis at, elementum convallis elit. Pellentesque enim turpis, hendrerit.</p>
									<p>Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis dapibus rutrum facilisis. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Etiam tristique libero eu nibh porttitor fermentum. Nullam venenatis erat id vehicula viverra. Nunc ultrices eros ut ultricies condimentum. Mauris risus lacus, blandit sit amet venenatis non, bibendum vitae dolor. Nunc lorem mauris, fringilla in aliquam at, euismod in lectus. Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. In non lorem sit amet elit placerat maximus. Pellentesque aliquam maximus risus, vel sed vehicula.</p>


									<hr class="major" />
									<h2>Case Study - Sino Biopharmaceutical</h2>
									<h3>Company Overview</h3>
									<p style="text-align:justify"><span class="image right"><img src="images/sino.png" alt="" /></span>Sino biopharma is an industry leader for generic drugs and specialize in liver related diseases. Through its continuous reformation and innovation in medical, pharmaceutical, and health fields, it has grown in size with more than 20 shareholding companies.  <br/><br/>
										It has a professional promotion team consisting of more than 10,000 employees, and nearly 1,000 kinds of products, covering all types of medical institutions at all levels across the country. We have launched more than 30 products with annual sales revenue of over 100 million CNY. Especially in the field of liver diseases, a number of major products have annual sales revenue exceeding 1 billion CNY, accounting for 24% in the overall sales income of the liver disease market in China.


<br/><br/>
Sino Boppharama has a competitive drug portfolio and robust R&D pipeline, with R&D spending percentage topping peers, as seen from the graph above.  Find out more at Sino Biopharma’s website at: <a target="_blank" href=http://www.sinobiopharm.com/en/#/>http://www.sinobiopharm.com/en/#/</a></p>

<h3>Recent Growth Catalysts</h3>

<p style="text-align:justify">Sino Biopharma’s competitive edge is developed by three main pillars, including a diverse R&D portfolio, strength in product distribution and rollout, participating in national reimbursement schemes, and having first to market advantages. These competitive edges has enabled Sino Biopharma to have higher margins, fewer industry competition, and a longer market shelf life.</p>
<span class="image fit"><img src="images/rd.png" alt="" /></span>
<br/>
<h3>Historical Performance Highlight</h3>
<p><span class="image left"><img src="images/sino_h.png" alt="" /></span>
	<b style="color:forestgreen">2010:</b> Admitted into HSI Consumer Goods and HSI Small Cap constituent stock<br/>
	<b style="color:cornflowerblue">2014:</b> Acquired Karoliska Development and became largest stakeholder<br/>
	<b style="color:gold">2015:</b> Acquired LifeBond, an Israel based medical device company, became 2nd  largest shareholder<br/>
	<b style="color:peru">2017: </b> Acquired 42% stake of Qingdao Chia Tai<br/>
	<b style="color:red">2018: </b> Government Policy on GPO (Group purchasing regulation) impact on pharma industry<br/>
	<b style="color:red">2018: </b> Acquired 24% of Beijing Tide<br/>
	<b style="color:red">2018: </b> Admitted into HSI Constituent stock<br/>
</p>


									<hr class="major" />
									<h2>Case Study - Hengrui Medicine</h2>
									<h3>Company Overview</h3>
									<p>Hengrui Medicine is a pharmaceutical company based in China focusing on research, development, manufacturing, and commercialization of innovative and high-quality healthcare products.</p>


									<p style="text-align:justify"><span class="image right"><img src="images/hr.png" alt="" /></span>
<ul>
																<li>Founded in 1970</li>
																<li>Market capitalization: USD 50 billion</li>
																<li>Employee: 24,700</li>
																		<li>Forbes’s top 100 world’s most innovative company </li>
																<li>Largest antitumor drug manufacturer in China (over 12% of market share)</li>
																<li>Key products: antitumor, surgical, endocrine, cardiovascular and anti-infective drugs</li>
															</ul>
									 </p>

<h3>Brand Pharma Valuation 
</h3>
<div class="row">

								<div class="col-4 col-12-medium">
												<h5>Highest R&D spender in China 
</h5>
												<span class="image fit"><img src="images/hr1.png" alt="" /></span>
											</div>
											<div class="col-4 col-12-medium">
												<h5>Strong sales force ensures monetization
</h5>
												<span class="image fit"><img src="images/hr2.png" alt="" /></span>
											</div>
											<div class="col-4 col-12-medium">
												<h5>Revenue breakdown by therapeutic area 
</h5>
												<span class="image fit"><img src="images/hr3.png" alt="" /></span>
											</div>
										</div>

<br/>
<h3>From generic pharma to brand pharma </h3>
<h4>From fast-follow to innovative drugs </h4>
<span class="image fit"><img src="images/hr4.png" alt="" /></span>
<h4>Company share price history </h4>
<p><span class="image left"><img src="images/hr5.png" alt="" /></span>
	<b style="color:black">Phase 1: 1997-2008</b> <br/>Focused on fast follow, aiming to replace foreign products<br/>
	<b style="color:black">Phase 2: 2008-2014</b> <br/>Commitment to innovative R&D (me better) and “go global” <br/>
	<b style="color:black">Phase 3: 2014-2018</b> <br/>Market generic drugs to overseas market; focus on genuinely innovative drugs  <br/>
</p>

								</section>

						</div>
					</div>

				<!-- Sidebar -->
					<div id="sidebar">
						<div class="inner">

							<!-- Search -->
								<section id="search" class="alt">
									<form method="post" action="#">
										<input type="text" name="query" id="query" placeholder="Search" />
									</form>
								</section>

							<!-- Menu -->
								<nav id="menu">
									<header class="major">
										<h2>Menu</h2>
									</header>
									<ul>
										<li><a href="index.html">Homepage</a></li>
										<li>
											<span class="opener">Industry Overview</span>
											<ul>
												<li><a href="#">Custom Segmentation: <br/>Individual v.s. Institution</a></li>
												<li><a href="#">Business Model: <br/>Generic Drug v.s. Drug Innovation</a></li>
												<li><a href="#">Overview of China Healthcare Industry</a></li>
												<li><a href="#">Overview of China Drug Industry</a></li>
											</ul>
										</li>
										<li>
											<span class="opener">Industry Value Chain</span>
											<ul>
												<li><a href="#">The Life of a Drug</a></li>
												<li><a href="#">Demystifying R&D + Drug Registration</a></li>
												<li><a href="#">Supply Chain and Major Players <br/>(Competitive Landscape) </a></li>
											</ul>
										</li>
										<li>
											<span class="opener">Success Factor</span>
											<ul>
												<li><a href="#">Robust R&D Pipeline</a></li>
												<li><a href="#">Policy & Regulation Support</a></li>
												<li><a href="#">Distribution Channel</a></li>
											</ul>
										</li>
										<li>
											<span class="opener">Future Trend</span>
											<ul>
												<li><a href="#">Regulation changes leading to change of industry dynamic</a></li>
											</ul>
										</li>
										<li><a href="#">Industrial Jardon</a></li>
										<li>
											<span class="opener">Case Study </span>
											<ul>
												<li><a href="#">Company 1 - Sino</a></li>
												<li><a href="#">Company 2 - Henrui</a></li>
											</ul>
										</li>
									</ul>
								</nav>

							<!-- Section -->
							<!--
								<section>
									<header class="major">
										<h2>Ante interdum</h2>
									</header>
									<div class="mini-posts">
										<article>
											<a href="#" class="image"><img src="images/pic07.jpg" alt="" /></a>
											<p>Aenean ornare velit lacus, ac varius enim lorem ullamcorper dolore aliquam.</p>
										</article>
										<article>
											<a href="#" class="image"><img src="images/pic08.jpg" alt="" /></a>
											<p>Aenean ornare velit lacus, ac varius enim lorem ullamcorper dolore aliquam.</p>
										</article>
										<article>
											<a href="#" class="image"><img src="images/pic09.jpg" alt="" /></a>
											<p>Aenean ornare velit lacus, ac varius enim lorem ullamcorper dolore aliquam.</p>
										</article>
									</div>
									<ul class="actions">
										<li><a href="#" class="button">More</a></li>
									</ul>
								</section>
-->
							<!-- Section -->
							<!--
								<section>
									<header class="major">
										<h2>Get in touch</h2>
									</header>
									<p>Sed varius enim lorem ullamcorper dolore aliquam aenean ornare velit lacus, ac varius enim lorem ullamcorper dolore. Proin sed aliquam facilisis ante interdum. Sed nulla amet lorem feugiat tempus aliquam.</p>
									<ul class="contact">
										<li class="icon solid fa-envelope"><a href="#">information@untitled.tld</a></li>
										<li class="icon solid fa-phone">(000) 000-0000</li>
										<li class="icon solid fa-home">1234 Somewhere Road #8254<br />
										Nashville, TN 00000-0000</li>
									</ul>
								</section>
-->
							<!-- Footer -->
								
						</div>
					</div>

			</div>

		<!-- Scripts -->
			<script src="assets/js/jquery.min.js"></script>
			<script src="assets/js/browser.min.js"></script>
			<script src="assets/js/breakpoints.min.js"></script>
			<script src="assets/js/util.js"></script>
			<script src="assets/js/main.js"></script>

	</body>
</html>